The DOI matches its Crossref record; 182 of the 185 references it cites were found in a registry or an index.
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Open accessAbstract
The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic apoptotic response. Recent advances in our understanding of apoptotic signaling pathways have enabled methods to identify cancers that are “primed” to undergo apoptosis, and have revealed potential biomarkers that may predict which cancers will undergo apoptosis in response to specific therapies. Complementary efforts have focused on developing novel drugs that directly target antiapoptotic BCL2 family proteins. In this review, we summarize the current knowledge of the role of BCL2 family members in cancer development and response to therapy, focusing on targeted therapeutics, recent progress in the development of apoptotic biomarkers, and therapeutic strategies designed to overcome deficiencies in apoptosis. Significance: Apoptosis, long known to be important for response to conventional cytotoxic chemotherapy, has more recently been shown to be essential for the efficacy of targeted therapies. Approaches that increase the likelihood of a cancer to undergo apoptosis following therapy may help improve targeted treatment strategies. Cancer Discov; 5(5); 475–87. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inhibition of MEK/ERK signaling leads to BIM accumulation and increases apoptotic priming in oncogene-driven cancers treated with various targeted therapies, driving cells into an MCL-1 and/or BCL-XL dependent state15,17.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Suppression of MEK/ERK signaling leads to the accumulation of the pro-apoptotic BCL-2 family protein BIM, which is critical for inducing apoptosis in response to an array of targeted therapies14,15.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [15]
In the citing paper
“Many studies have established a central role of the pro-apoptotic BH3 protein BIM in mediating the apoptotic response to targeted therapies (reviewed in [116]).”
From Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer (2021) · cites this paper as [116]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
Self-citation
Cited by
Sorted by citations
Items 401–500 of 625
Sun, L., Sun, C., Sun, J., & Yang, W. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.9969 · Cited by 9
BAX is an essential key mediator of AP5M1-induced apoptosis in cervical carcinoma cells
Won, M., Luo, Y., Lee, D.-H., Shin, E., Suh, D., Kim, T., Jin, H., & Bae, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.065 · Cited by 9
Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
Liang, H., Xu, M., Xiong, Z., Hu, K., Yang, J., Cao, M., Zhong, Z., Yao, Z., Deng, M., & Liu, B. (2021) · Aging · doi:10.18632/aging.202606 · Cited by 9
Quentmeier, H., Geffers, R., Hauer, V., Nagel, S., Pommerenke, C., Uphoff, C. C., Zaborski, M., & Drexler, H. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-04916-6 · Cited by 9
Targeting Apoptosis as a Therapeutic Approach in Cancer
Abd-Elhamid, R., Nazmy, M., & Fathy, M. (2020) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.221093 · Cited by 9
Liu, H., Ye, Z., Kan, S., Hao, M., Jiang, H., Li, S., Li, R., Wang, Y., Wang, D., & Liu, W. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29291 · Cited by 8
Squillaci, G., Vitiello, F., Mosca, L., Cara, F. L., Cacciapuoti, G., Porcelli, M., & Morana, A. (2022) · Molecules · doi:10.3390/molecules27082576 · Cited by 8
Isoyama, S., Tamaki, N., Noguchi, Y., Okamura, M., Yoshimatsu, Y., Kondo, T., Suzuki, T., Yaguchi, S., & Dan, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05690-7 · Cited by 8
Histidine triad nucleotide-binding protein 2: From basic science to clinical implications
Yao, J., Miao, Y., Zhu, L., Wan, M., Lu, Y., & Tang, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115527 · Cited by 8
Shamsudin, N. F., Leong, S. W., Koeberle, A., Suriya, U., Rungrotmongkol, T., Chia, S. L., Taher, M., Haris, M. S., Alshwyeh, H. A., Alosaimi, A. A., et al. (2024) · Future Medicinal Chemistry · doi:10.1080/17568919.2024.2363668 · Cited by 8
Yu, Z., Guo, J., Meng, T., Ge, L., Liu, L., Wang, H., & Yang, X. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00553-x · Cited by 8
Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines
Pruteanu, L.-L., Braicu, C., Módos, D., Jurj, M.-A., Ráduly, L., Zănoagă, O., Magdo, L., Cojocneanu, R., Paşca, S., Moldovan, C. S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094784 · Cited by 8
Lei, Y., Zhang, B., Zhang, Y., Zhao, Y., Sun, J., Zhang, X., & Yang, S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3603 · Cited by 8
Wang, J., Li, S., Lin, S., Fu, S., Qiu, L., Ding, K., Liang, K., & Du, H. (2020) · Cell Proliferation · doi:10.1111/cpr.12826 · Cited by 7
Hadžić, M., Pojskić, L., Lojo-Kadrić, N., Haverić, A., Ramić, J., Galić, B., & Haverić, S. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23005 · Cited by 8
Zhao, Z.-D., Yang, Y., Liu, W., & Li, Z. (2018) · Molecules · doi:10.3390/molecules23061251 · Cited by 8
Mmu_circ_0000037 inhibits the progression of acute pancreatitis by miR‐92a‐3p/Pias1 axis
Chen, H., Tu, J., He, L., Gao, N., & Yang, W. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.819 · Cited by 7
Computational modeling of DLBCL predicts response to BH3-mimetics
Cloete, I., Smith, V. M., Jackson, R. A., Pepper, A. G. S., Pepper, C. J., Vogler, M., Dyer, M. J. S., & Mitchell, S. A. (2023) · npj Systems Biology and Applications · doi:10.1038/s41540-023-00286-5 · Cited by 7
Mannan, A., Mohan, M., & Singh, T. G. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104707 · Cited by 7
Anti-cancer binary system activated by bacteriophage HK022 integrase
Elias, A., Spector, I., Gritsenko, N., Zilberstein, Y., Gorovits, R., Prag, G., & Kolot, M. N. (2018) · Oncotarget · doi:10.18632/oncotarget.25512 · Cited by 7
LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4
Ning, J., Zhang, L., Guo, H., Zhou, S., Sun, X., & Bao, W. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.12.41 · Cited by 7
Ruiz-Yance, I. O., Siguas-Peña, J. F., Bardales, B., Robles-Castañeda, I., Cordova, K., Ypushima, A., Estela-Villar, E., Quintana-Criollo, C., Estacio, D., & Rodríguez, J.-L. (2023) · Toxics · doi:10.3390/toxics11100839 · Cited by 8
Anticancer Activity of Secondary Metabolites of Teucrium Species
Milutinović, M. G., & Cvetković, D. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-52159-2_13 · Cited by 7
Radioprotective effects of centipedegrass extract on NIH‑3T3 fibroblasts via anti‑oxidative activity
Kang, S. H., Bak, D., Lee, S. M., Bai, H., Chung, B. Y., & Kang, B. S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9863 · Cited by 7
Soliman, L. B., Souza, A. O., Srinivasan, P. R., Danish, M. L., Bertone, P., El‐Deiry, W. S., & Carneiro, B. A. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000829 · Cited by 7
Carcinogenesis: Mechanisms and Evaluation
Hoenerhoff, M. J., Boyle, M. H., Minocherhomji, S., & Pandiri, A. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821044-4.00013-3 · Cited by 9
Liu, M., Wang, W., Wang, H., Zhao, S., Yin, D., Zhang, H., Zou, C., Zou, S., Yu, J., & Wei, Y. (2025) · Marine Drugs · doi:10.3390/md23080304 · Cited by 6
Hsa_circ_0001615 downregulation inhibits esophageal cancer development through miR-142-5p/β-catenin
Dai, Y., Xu, Q., Xia, M., Chen, C., Xiong, X., Yang, X., & Wang, W. (2024) · PeerJ · doi:10.7717/peerj.17089 · Cited by 6
Wang, Y., Tian, X., Cheng, T., Liu, R., & Han, F. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2373957 · Cited by 8
MicroRNA-101a protects against the H2O2-induced injury on cardiomyocytes via targeting BCL2L11.
Zhai, C., Hu, H., Tang, G., Pan, H., Zhang, Y., & Qian, G. (2020) · PubMed Central · Cited by 6
MicroRNA-222 alleviates radiation-induced apoptosis by targeting BCL2L11 in cochlea hair cells
Zhang, Y., Xiong, G., & Xie, X. (2021) · Bioscience Reports · doi:10.1042/bsr20201397 · Cited by 7
Aka, Y., Karakaş, B., Acikbas, U., Başağa, H., Gül, Ö., & Kütük, Ö. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106028 · Cited by 6
Apatinib enhances chemosensitivity of ABT ‐199 in diffuse large B‐cell lymphoma
Shi, Y., Ye, J., Shen, H., Xu, Y., Wan, R., Ye, X., Jin, J., & Xie, W. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13309 · Cited by 7
Meligova, A. K., Siakouli, D., Stasinopoulou, S., Xenopoulou, D. S., Zoumpouli, M., Ganou, V., Gkotsi, E., Chatziioannou, A. A., Papadodima, O., Pilalis, E. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043747 · Cited by 6
Topical Administration of an Apoptosis Inducer Mitigates Bleomycin-Induced Skin Fibrosis
Huda, M. N., Borrego, E. A., Guerena, C. D., Varela-Ramı́rez, A., Aguilera, R. J., Hamadani, C. M., Tanner, E. E. L., Badruddoza, A. Z. M., Agarwal, S. K., & Nurunnabi, M. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00039 · Cited by 6
Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors
Ismail, H. S., Khalil, A. I., Taha, R. A., Lasheen, D. S., & Ella, D. A. A. E. (2023) · Scientific Reports · doi:10.1038/s41598-023-41783-1 · Cited by 6
Wahab, N. A. A., Abas, F., Othman, I., & Naidu, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707335 · Cited by 6
Aasebø, E., Brenner, A. K., Hernandez-Valladares, M., Birkeland, E., Reikvam, H., Selheim, F., Berven, F. S., & Bruserud, Ø. (2021) · Hemato · doi:10.3390/hemato2030039 · Cited by 6
de Souza, S. M., de Souza, L. S., Silva, V. R., Soares, M. B. P., Bezerra, D. P., Góis, R. W. D. S., da Silva, H. C., Santiago, G. M. P., & Militão, G. C. G. (2022) · Planta Medica · doi:10.1055/a-1910-5776 · Cited by 6
Kuwana, T. (2018) · Advances in biomembranes and lipid self-assembly · doi:10.1016/bs.abl.2017.12.002 · Cited by 6
Lorenzo‐Herrero, S., Sordo‐Bahamonde, C., Bretones, G., Páyer, Á. R., González, A. P., González-García, E., Pérez‐Escuredo, J., Villa-Álvarez, M., Núñez, L. E., Morís, F., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02455 · Cited by 5
Drug Resistance and Its Clinical Circumvention
Moscow, J. A., Hughes, S. K., Cowan, K. H., & Sikic, B. I. (2022) · Holland‐Frei Cancer Medicine · doi:10.1002/9781119000822.hfcm063.pub2 · Cited by 6
Beyond Docetaxel: Targeting Resistance Pathways in Prostate Cancer Treatment
Adekiya, T. A. (2025) · BioChem · doi:10.3390/biochem5030024 · Cited by 5
Hartman, M. L., Koziej, P., Kluszczyńska, K., & Czyż, M. (2023) · Cancers · doi:10.3390/cancers15194799 · Cited by 5
Liu, L., Yu, T., Liao, T.-S., Xu, P., Wang, Y., Shi, M., & Li, B. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i10.1756 · Cited by 5
Kesarwani, M., Kincaid, Z., Azhar, M., & Azam, M. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023010830 · Cited by 5
Goel, K. K., Rawat, P., Murti, Y., Mahajan, S., Kandhari, H., Kumar, B., & Dwivedi, A. R. (2024) · ChemistrySelect · doi:10.1002/slct.202401707 · Cited by 5
Shang, J., Liu, L., Yang, S., Duan, B., Xie, S., & Meng, X. (2024) · Foods · doi:10.3390/foods13193054 · Cited by 5
Wang, Y., Li, Y., Zhang, Y., Li, Y., Zhao, L., Tong, L., Zhu, X. M., Wang, J., & Dong, Y. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111562 · Cited by 5
Promising Anticancer Effect of Aurisin A Against the Human Lung Cancer A549 Cell Line
Boueroy, P., Boonmars, T., Kanokmedhakul, S., Chareonsudjai, S., Lekphrom, R., & Srichangwang, S. (2020) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2020.21.1.49 · Cited by 5
FNC inhibits non-small cell lung cancer by activating the mitochondrial apoptosis pathway
Xiang, J., Niu, S., Liang, Y., Chen, H., Wang, N., Peng, Y., Ma, F., Yue, W., Wang, Q., Chang, J., et al. (2021) · Genes & Genomics · doi:10.1007/s13258-021-01179-9 · Cited by 5
Mohammadi, A., Mansoori, B., Safarzadeh, E., Gholizadeh, S., & Baradaran, B. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100649 · Cited by 5
Li, L., Huang, T., Lan, C., Jia, A., & Mao, Y. (2017) · Biologia · doi:10.1515/biolog-2017-0155 · Cited by 5
Sabokrouh, A., Atabi, F., Jassem, R. M., & Mohammadi, R. (2019) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-019-00296-9 · Cited by 5
Action of Akt Pathway on La-Induced Hippocampal Neuron Apoptosis of Rats in the Growth Stage
Wang, J., Wu, T., Ma, L., Guo, Y., Huang, Y., & Zheng, L. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00206-z · Cited by 5
Xu, W., Chen, B., Ke, D., & Chen, X. (2021) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0144 · Cited by 5
Kurasug, B., Kukongviriyapan, V., Prawan, A., Yenjai, C., & Kongpetch, S. (2018) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v17i7.16 · Cited by 5
Lu, J., Lv, L., Tian, X., Li, Z., Ma, Y., Li, N., Wang, J., Wang, G., Zeng, Y., Zhang, W., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102476 · Cited by 4
Wei, Y., Jiang, X., Song, J., Yan, X., Zhang, J., Dong, F., Li, D., Liu, H., & Lu, F. (2025) · Fitoterapia · doi:10.1016/j.fitote.2025.106602 · Cited by 4
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA -Mutant Colorectal Cancer
DeStefanis, R. A., Schmitz, A. E., Steimle, A. K., Payne, S. N., Sha, G. C., Olson, A. M., Cornelio, A. B., Lippert, A. E. L., Kraus, S. G., Johnson, K. A., et al. (2025) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-1096 · Cited by 4
de Lima, A. B., Gonçalves, B. Ô. P., Moreira, M. P., Barros, B. A. F., Filho, A. L. D. S., Fialho, S. L., Braga, L. D. C., & Silva, L. M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152322 · Cited by 4
Wang, J., Yue, Z., Bu, J., Quan, S., Guo, R., Wang, M., Shen, J.-D., Li, M., & Li, Y. (2025) · Medical Oncology · doi:10.1007/s12032-025-02919-7 · Cited by 4
Watanabe, M., Boku, S., Kobayashi, K., Kurumida, Y., Sukeno, M., Masuda, M., Mizushima, K., Kato, C., Iizumi, Y., Hirota, K., et al. (2022) · PNAS Nexus · doi:10.1093/pnasnexus/pgac059 · Cited by 4
Mammalian eIF4E2-GSK3β maintains basal phosphorylation of p53 to resist senescence under hypoxia
Sun, L., He, Y., He, D., Chen, J., Dong, Z., Luo, S., Liang, H., Cao, Y., Cai, B., & Zhang, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04897-4 · Cited by 6
Jaya, I., Safriadi, F., Wijaya, I., Pitaloka, P., Afifah, E., Medina, F. S., & Bashari, M. H. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104895 · Cited by 5
Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
Modica, C., Gallo, S., Chiriaco, C., Spilinga, M., Comoglio, P. M., Crepaldi, T., Basilico, C., & Vigna, E. (2020) · Cancers · doi:10.3390/cancers12030741 · Cited by 4
Kater, L., Kater, B., Jakupec, M. A., Keppler, B. K., & Prokop, A. (2021) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-021-01900-9 · Cited by 4
Mora, D. P. P., Murillo, O. J., Buitrago, M. R., Losada-Barragán, M., Uribe, J. F. C., Santiago, K. B., Conti, B. J., Cardoso, E. D. O., Conte, F. L., Gutiérrez, R. M., et al. (2021) · Veterinary World · doi:10.14202/vetworld.2021.964-971 · Cited by 4
Cupido-Sánchez, M. G., Herrera-González, N. E., Barrera-Mendoza, C. C., Hernández, M. L. M., & Ramón‐Gallegos, E. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.102106 · Cited by 4
Tiribelli, M., Michelutti, A., Cavallin, M., Giusto, S. D., Fanin, R., & Damiani, D. (2021) · Turkish Journal of Hematology · doi:10.4274/tjh.galenos.2021.2020.0728 · Cited by 4
Anti-colorectal cancer effect and mechanism of a polysaccharide from Ruditapes philippinarum
Zhang, X., Liu, M., Zhang, X., Du, Z., Yuxi, W., & Li, F. (2025) · European Journal of Nutrition · doi:10.1007/s00394-025-03794-8 · Cited by 3
Tng, T. J. W., Cheah, I. K.-M., Halliwell, B. B., & Lim, K. (2026) · Antioxidants · doi:10.3390/antiox15040519 · Cited by 3
Deciphering the topological landscape of glioma using a network theory framework
Yao, M.-C., Su, Y., Xiong, R., Zhang, X., Zhu, X., Chen, Y.-C., & Ao, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-77856-y · Cited by 4
Keser, M., & Atmaca, H. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-03923-6 · Cited by 3
Xu, J., & Luo, J. (2017) · PubMed Central · doi:10.7499/j.issn.1008-8830.2017.08.018 · Cited by 3
Chemotherapy drug potency assessment method of ovarian cancer cells by digital holography microscopy
Liu, Y., Xiao, W., Zhang, H., Lu, X., Li, X., & Pan, F. (2022) · Biomedical Optics Express · doi:10.1364/boe.465149 · Cited by 3
The Pt(S-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo
Silconi, Ž. B., Rosic, V., Benazic, S., Radosavljevic, G. D., Mijajlović, M. Ž., Pantic, J. M., Ratković, Z., Radić, G. P., Arsenijević, A., Milovanović, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158161 · Cited by 3
Huang, T., Chen, C., Lan, Y., Lin, S.-S., Choo, K., & Chong, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314884 · Cited by 3
Hedayati, N., Naeini, M. S., Sahebfosoul, M. M. A., Mafi, A., Milasi, Y. E., Rizaneh, A., Nabavi, N., Farahani, N., Alimohammadi, M., & Ghezelbash, B. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155478 · Cited by 3
Li, C., Zhao, Y., He, C., Wang, X., Ren, Q., Gai, X., & Wang, H. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155792 · Cited by 3
Aal, F. S. A., Al‐Shahed, F. A. N., & Al-Saeed, H. F. (2016) · Al-Azhar Medical Journal · doi:10.12816/0029134 · Cited by 3
Lodh, S., & Swamy, M. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-2361-8_20 · Cited by 3
Anti-proliferative Properties of p-Coumaric Acid in SNU-16 Gastric Cancer Cells
Jang, M. G., 고희철, & Kim, S. (2019) · Cited by 3
Pathology and Molecular Pathogenesis of DLBCL and Related Entities
Pasqualucci, L., & Ott, G. (2018) · Methods in molecular biology · doi:10.1007/978-3-030-00362-3_2 · Cited by 4
Extracellular Vesicles as Biomarkers and Therapeutic Targets in Cancers
Barnie, P. A., Afrifa, J., Gyamerah, E. O., & Amoani, B. (2022) · Physiology · doi:10.5772/intechopen.101783 · Cited by 3
Titus, S., Szymańska, K. J., Musul, B., Turan, V., Taylan, E., García-Milian, R., Mehta, S. S., & Oktay, K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.23.167783 · Cited by 3
Activation of the Integrated Stress Response overcomes multidrug resistance in FBXW7-deficient cellsPreprint
Sanchez‐Burgos, L., Navarro‐González, B., García‐Martín, S., Tejero, H., Antón, M. E., Al‐Shahrour, F., & Fernández-Capetillo, Ó. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.17.476566 · Cited by 3
Gupta, S. R. R., Mittal, P., Kundu, B., Singh, A. K., & Singh, I. K. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2268176 · Cited by 2
Ye, J., Wei, B., Zhou, G., Xu, Y., He, Y., Hu, X., Chen, X., Zhang, G., & Liu, H. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00930-0 · Cited by 2
Kopparapu, P., Löhr, C. V., Pearce, M. C., Tyavanagimatt, S., Nakshatri, H., & Kolluri, S. K. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00360 · Cited by 2
The Role of the BCL2 Family in Targeted Anticancer Response as Apoptotic Mediators
Roufayel, R., & Abdullah, S. (2025) · The Open Medicinal Chemistry Journal · doi:10.2174/0118741045413023251029095309 · Cited by 2
Alabaş, E., & Özçimen, A. A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11284-7 · Cited by 2
Wang, A., Qi, D., Ma, Y., Wang, M., Dong, H., Wang, C., Zhang, Y., Zhang, Z., Li, L., Xu, J. H., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02512-6 · Cited by 2
Design, Synthesis, and Evaluation of Phenylpyrrole Derivatives as Small-Molecule Activators of BAX
Cai, W., Li, Z., Zhao, M., Gu, Y., Qiu, C., Zhou, M., Deng, W., Zhou, L., Li, Y., & Wang, R. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02670 · Cited by 2
Potential Mechanisms of Metformin-Induced Apoptosis in HeLa Cells
Chu, Z., Tan, Y., Xu, C., Zhangsun, D., & Zhu, X. (2023) · Biomolecules · doi:10.3390/biom13060950 · Cited by 2
PLP2 Could Be a Prognostic Biomarker and Potential Treatment Target in Glioblastoma Multiforme
Qiao, H., & Li, H. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s425251 · Cited by 2
Kim, S. H., Chun, C., & Yoon, T. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.3c05801 · Cited by 2
PAQR4 oncogene: a novel target for cancer therapy
Patil, D., Raut, S., Joshi, M., Bhatt, P., & Bhatt, L. K. (2024) · Medical Oncology · doi:10.1007/s12032-024-02382-w · Cited by 2
Abdollahzadeh, N., & Tafrihi, M. (2025) · Egyptian Journal of Basic and Applied Sciences · doi:10.1080/2314808x.2024.2448403 · Cited by 2
The role of BIM gene deletion in ALK-mutated Non-small cell lung cancer treated with alectinib
Hou, S., Zhang, W., Pang, W., Xia, H., Tan, J., Huang, Q., & Yang, P. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01579-1 · Cited by 2
Metadata
- Authors
- Hata, A. N., Engelman, J. A., & Faber, A. C.
- Affiliations
- Harvard University (US)
- Virginia Commonwealth University (US)
- Corresponding author
- Engelman, Jeffrey A.
- Faber, Anthony C.
- Venue
- Cancer Discovery
- Published
- 2015-05-01
- Volume
- 5
- Issue
- 5
- Pages
- 475-487
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC4727530
- OpenAlex
- W2067275727
- Cited by
- 619
- References
- 185
- Citations by year
- 2026: 19 · 2025: 48 · 2024: 46 · 2023: 42 · 2022: 69 · 2021: 79 · 2020: 83 · 2019: 79 · 2018: 73 · 2017: 45 · 2016: 29 · 2015: 6
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (P50CA127003, R01CA140594, R01CA164273, R01CA137008)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Bcl-2 family proteins, apoptosis, targeted cancer therapy, mitochondrial apoptosis, cancer therapy response, carcinogenesis, apoptosis resistance
- MeSH terms
- Bcl-2-Like Protein 11, Animals, Antineoplastic Agents, Humans, Membrane Proteins, Neoplasms, Proto-Oncogene Proteins, Signal Transduction, Biomarkers, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review